Actively Recruiting
Influence of Cerebral Oedema in Intracerebral Haemorrhage
Led by University Hospital, Lille · Updated on 2026-04-22
500
Participants Needed
1
Research Sites
339 weeks
Total Duration
On this page
Sponsors
U
University Hospital, Lille
Lead Sponsor
C
Conseil Régional Hauts-de-France, France
Collaborating Sponsor
AI-Summary
What this Trial Is About
In 2020, IntraCerebral Haemorraghe (ICH) remains the most devastating type of stroke. Besides stroke unit care, no specific treatment has been proven effective yet. Perihaematomal oedema (PHO) could be a promising therapeutic target. However, the mechanisms, the natural history as well as the clinical impact of this PHO remain unclear. The COPITCH study has been designed to answer these questions
CONDITIONS
Official Title
Influence of Cerebral Oedema in Intracerebral Haemorrhage
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Have a spontaneous (non-traumatic) intracerebral haemorrhage
- Admitted to the hospital within 12 hours of stroke onset (or last seen well for wake-up strokes)
- Covered by French social security insurance
- Signed the consent form
You will not qualify if you...
- Have pure intraventricular haemorrhages
- Have secondary intracerebral haemorrhage caused by vascular malformation, venous thrombosis, head trauma, tumor, or haemorrhagic transformation of an infarct
- Pre-admission modified Rankin score of 4 or 5
- Life expectancy less than 1 year due to serious other medical conditions
- Are pregnant, breastfeeding, or a woman of childbearing age without effective contraception
- Are deprived of liberty by judicial or administrative decision
- Are referred from other hospitals
- Have contraindications to MRI such as claustrophobia, metallic eye foreign bodies, implanted medical devices, metal heart valves, vascular clips, or gadolinium allergy
- Have not signed the consent form
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
CHU de Lille
Lille, France, 59037
Actively Recruiting
Research Team
C
Charlotte Cordonnier, MD,PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here